[On the work by S. Reith and H. G. Klues "Therapy and risk-stratification in hypertrophic cardiomyopathy", Z Kardiol 92: 283-293 (2003)].
D002312:Cardiomyopathy, Hypertrophic / Q000145:classification / Q000401:mortality* / Q000503:physiopathology / Q000628:therapy*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy / Q000379:methods / Q000401:mortality; D016757:Death, Sudden, Cardiac / Q000453:epidemiology / Q000517:prevention & control; D017147:Defibrillators, Implantable; D006346:Heart Septum / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D019060:Minimally Invasive Surgical Procedures; D010138:Pacemaker, Artificial; D015996:Survival Rate; D014694:Ventricular Outflow Obstruction / Q000145:classification / Q000401:mortality* / Q000503:physiopathology / Q000628:therapy*
D002317:Cardiovascular Agents